Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
Saved in:
| Title: | Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses. |
|---|---|
| Authors: | Fedoriw A; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Shi L; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., O'Brien S; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Smitheman KN; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Wang Y; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hou J; Department of Biology and Biochemistry, University of Houston, Houston, Texas., Sherk C; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Rajapurkar S; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Laraio J; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Williams LJ; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Xu C; Department of Biology and Biochemistry, University of Houston, Houston, Texas., Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Feng Q; Department of Biology and Biochemistry, University of Houston, Houston, Texas., Bedford MT; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Smithville, Texas., Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas., Barbash O; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Kruger RG; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Hwu P; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Mohammad HP; Tumor Cell Targeting Research Unit, GlaxoSmithKline, Collegeville, Pennsylvania., Peng W; Department of Biology and Biochemistry, University of Houston, Houston, Texas. |
| Source: | Cancer immunology research [Cancer Immunol Res] 2022 Apr 01; Vol. 10 (4), pp. 420-436. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
